enCore Energy Corp. (EU)
Price:
3.25 USD
( - -0.06 USD)
Your position:
0 USD
ACTION PANEL
ABOUT
Check the
KEY TAKEAWAYS
ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
(REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION
SIMILAR COMPANIES STI SCORE
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS
FUNDAMENTALS PER SHARE
TECHNICAL
DIVIDEND
SIMILAR COMPANIES
DESCRIPTION
enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. It holds a 100% interest in Crownpoint and Hosta Butte uranium project area covers 3,020 acres located in the Grants Uranium Belt, New Mexico. The company also holds interest in the Marquez-Juan Tafoya property comprises 14,582 acres located in McKinley and Sandoval counties of New Mexico; and the Nose Rock project comprising 42 owned unpatented lode mining claims comprising approximately 800 acres located in McKinley County, New Mexico. In addition, it holds interest in the White Canyon District and Utah property package, including the Geitus, Blue Jay, Marcy Look, and Cedar Mountain projects located to the northwest of the White Mesa Mill at Blanding County, Utah. Further, the company holds a 100% interest in Dewey Burdock project comprises approximately 12,613 surface acres and 16,962 net mineral acres located in South Dakota; Gas Hills project consists of approximately 1,280 surface acres and 12,960 net mineral acres of unpatented lode mining claims located in Wyoming; and West Largo project consist of approximately 3,840 acres located in McKinley County, New Mexico. Additionally, it holds a 100% interest in Ambrosia Lake - Treeline property consists of deeded mineral rights totaling 24,555 acres and unpatented mining claims covering approximately 1,700 acres; and Checkerboard mineral rights covering a land position of approximately 300,000 acres located in the Grants Uranium District. The company was formerly known as Wolfpack Gold Corp. and changed its name to enCore Energy Corp. in August 2014. enCore Energy Corp. is headquartered in Corpus Christi, Texas.
NEWS
enCore Energy Corp. Appoints Ms. Ashley Forbes as Vice President, Permitting and Regulatory Affairs
prnewswire.com
2025-10-01 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Oct. 1, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the appointment of Ms. Ashley Forbes as Vice President, Permitting and Regulatory Affairs, effective immediately.
enCore Energy's Dewey Burdock ISR Uranium Project EPA Decision Advances Federal Permitting
prnewswire.com
2025-09-16 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Sept. 16, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that the U.S. Environmental Protection Agency's ("EPA") Environmental Appeals Board ("EAB") has denied in full a petition for review filed by the Oglala Sioux Tribe, Black Hills Clean Water Alliance, and NDN Collective (the "Petitioners") against the EPA's issuance of Class III and Class V Underground Injection Control ("UIC") permits for the Company's 100%-owned Dewey Burdock In-Situ Recovery ("ISR") Uranium Project ("Dewey Burdock Project") in South Dakota.
enCore Energy Corp. Appoints Mr. Kevin Kremke as Chief Financial Officer
prnewswire.com
2025-09-10 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Sept. 10, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the appointment of Mr.
enCore Energy Corp. Announces the Dewey Burdock ISR Uranium Project Approved for United States Government Fast-Track Permitting; First South Dakota Critical Minerals Project Added to Fast-41
prnewswire.com
2025-09-02 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Sept. 2, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that its Dewey Burdock ISR Uranium Project ("Dewey Burdock Project"), located in South Dakota, has been approved for inclusion in the Fast-41 Program by the U.S. Federal Permitting Improvement Steering Council ("Permitting Council").
enCore Energy Corp. Hosts Corporate Update
prnewswire.com
2025-08-25 17:49:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 25, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced William M. Sheriff, Executive Chairman, and Robert Willette, A/Chief Executive Officer are hosting a corporate update on Wednesday, August 27 th at 1:15PM ET.
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
globenewswire.com
2025-08-25 03:00:00TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the anti-amyloid beta (Aβ) monoclonal antibody “LEQEMBI®” has been launched in Austria on August 25, 2025 and will be launched in Germany on September 1, 2025. LEQEMBI received the European Commission (EC) approval in April 2025 as the first therapy that targets an underlying cause of Alzheimer's disease (AD). It is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment (MCI) and mild dementia due to AD ( collectively referred to as early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or heterozygotes with confirmed amyloid pathology.1 Germany and Austria will mark the first launches in the EU.
enCore Energy Corp. Completes Upsized $115 Million Offering of Senior Convertible Notes
prnewswire.com
2025-08-22 16:15:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 22, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today it has closed its previously announced offering of $115 million aggregate principal amount of 5.50% Convertible Senior Notes due 2030 (the "Convertible Notes"), which includes the upsized offering of $100 million and the exercise in full of the $15 million option granted to the initial purchasers of the Convertible Notes. The initial conversion rate for the Convertible Notes is 303.9976 common shares per $1,000 principal amount of notes, which represents an initial conversion price of $3.2895 per common share.
enCore Energy Corp. Prices Upsized $100 Million Convertible Senior Notes Offering
prnewswire.com
2025-08-20 06:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 20, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the pricing of $100 million aggregate principal amount of 5.50% Convertible Senior Notes due 2030 (the "Convertible Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previously announced offering size of $75 million aggregate principal amount of Convertible Notes.
enCore Energy Corp. Announces Proposed Offering of $75 Million of Convertible Senior Notes Due 2030
prnewswire.com
2025-08-19 16:10:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 19, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that it intends to offer, subject to market and other conditions, $75 million in aggregate principal amount of convertible senior notes due 2030 (the "Convertible Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). In connection with the offering of the Convertible Notes, enCore expects to grant the initial purchasers of the Convertible Notes a 13-day right to purchase up to an additional $11.25 million aggregate principal amount of Convertible Notes.
enCore Energy Announces Expansion of the Alta Mesa Uranium Project
prnewswire.com
2025-08-18 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 18, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced the acquisition of a 5,900 acre parcel of private land ("Tacubaya") located immediately adjacent to, and east of, enCore's Alta Mesa historic and producing wellfields and Central Processing Plant ("Alta Mesa Uranium Project"). Tacubaya is expected to provide additional feed and longevity for the Alta Mesa In-Situ Recovery ("ISR") Uranium Central Processing Plant ("CPP").
enCore Energy Reports Q2 2025 Financial Results, Highlighted by Increased Uranium Extraction Rates and Reduced Costs
prnewswire.com
2025-08-11 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 11, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, today announced its financial and operational results for the six months ended June 30, 2025. Highlights for three months ended June 30, 2025 include: Three months ended June 30, 2025 net loss per share $(0.03) versus $(0.12) in same period 2024; Sale (delivery) into contract of 60,000 pounds of uranium ("U3O8") at a sales price of $61.07 and a weighted average cost of $42.23; Three months ended June 30 U3O8 extraction of 203,798 pounds, an increase of 89,983 pounds or an increase of 79% from the first quarter of 2025; Closing balance of 244,204 pounds of U3O8 in inventory at a cost of $39.63 per pound; Closing cash and equivalent balance of $26.9 million with working capital of $30.2 million.
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
prnewswire.com
2025-07-24 17:42:00The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market before the end of Q3 2025 GREENFIELD, Ind. , July 24, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Zenrelia™ (ilunocitinib) has received approval by the European Commission.
Down 40%, This 1 Super Growth Stock Can Double By 2026
247wallst.com
2025-07-14 09:29:19Key Points in This Article: enCore Energy's (EU) operational ISR plants and project pipeline position it to meet rising U.S.
enCore Energy Announces High Uranium Extraction Rates in South Texas; Commends Texas for Energizing its Nuclear Energy Strategy with Passage of Three Key Bills
prnewswire.com
2025-06-26 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , June 26, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today record uranium extraction rates from the Alta Mesa In-Situ Recovery ("ISR") Uranium Central Processing Plant ("CPP") since commencing operations in June 2024. Recent management changes and operational efficiencies have worked to expand uranium extraction and decrease costs.
enCore Energy Announces Filing of Early Warning Report
prnewswire.com
2025-06-20 19:57:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , June 20, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announces that it has disposed of 170,000,000 common shares in the capital of Anfield Energy Inc. (" Anfield ") (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) in a private agreement at a price of $0.115 per share for aggregate proceeds of $19,550,000 (Canadian dollars). Immediately following the disposition, enCore holds or controls no common shares of Anfield.
Guide to Aerospace & Defense ETFs
zacks.com
2025-06-05 08:31:03Defense spending hit a record $2.72T in 2024, boosting aerospace sector earnings as global tensions drive military budgets higher. ETFs like ITA, PPA and XAR are likely to gain.
enCore Energy Corp. Appoints Ms. Ashley Forbes as Vice President, Permitting and Regulatory Affairs
prnewswire.com
2025-10-01 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Oct. 1, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the appointment of Ms. Ashley Forbes as Vice President, Permitting and Regulatory Affairs, effective immediately.
enCore Energy's Dewey Burdock ISR Uranium Project EPA Decision Advances Federal Permitting
prnewswire.com
2025-09-16 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Sept. 16, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that the U.S. Environmental Protection Agency's ("EPA") Environmental Appeals Board ("EAB") has denied in full a petition for review filed by the Oglala Sioux Tribe, Black Hills Clean Water Alliance, and NDN Collective (the "Petitioners") against the EPA's issuance of Class III and Class V Underground Injection Control ("UIC") permits for the Company's 100%-owned Dewey Burdock In-Situ Recovery ("ISR") Uranium Project ("Dewey Burdock Project") in South Dakota.
enCore Energy Corp. Appoints Mr. Kevin Kremke as Chief Financial Officer
prnewswire.com
2025-09-10 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Sept. 10, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the appointment of Mr.
enCore Energy Corp. Announces the Dewey Burdock ISR Uranium Project Approved for United States Government Fast-Track Permitting; First South Dakota Critical Minerals Project Added to Fast-41
prnewswire.com
2025-09-02 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Sept. 2, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that its Dewey Burdock ISR Uranium Project ("Dewey Burdock Project"), located in South Dakota, has been approved for inclusion in the Fast-41 Program by the U.S. Federal Permitting Improvement Steering Council ("Permitting Council").
enCore Energy Corp. Hosts Corporate Update
prnewswire.com
2025-08-25 17:49:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 25, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced William M. Sheriff, Executive Chairman, and Robert Willette, A/Chief Executive Officer are hosting a corporate update on Wednesday, August 27 th at 1:15PM ET.
Austria and Germany to become the first markets in the European Union (EU) to launch LEQEMBI® (lecanemab)
globenewswire.com
2025-08-25 03:00:00TOKYO and CAMBRIDGE, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today that the anti-amyloid beta (Aβ) monoclonal antibody “LEQEMBI®” has been launched in Austria on August 25, 2025 and will be launched in Germany on September 1, 2025. LEQEMBI received the European Commission (EC) approval in April 2025 as the first therapy that targets an underlying cause of Alzheimer's disease (AD). It is indicated for the treatment of adult patients with a clinical diagnosis of mild cognitive impairment (MCI) and mild dementia due to AD ( collectively referred to as early AD) who are apolipoprotein E ε4 (ApoE ε4*) non-carriers or heterozygotes with confirmed amyloid pathology.1 Germany and Austria will mark the first launches in the EU.
enCore Energy Corp. Completes Upsized $115 Million Offering of Senior Convertible Notes
prnewswire.com
2025-08-22 16:15:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 22, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today it has closed its previously announced offering of $115 million aggregate principal amount of 5.50% Convertible Senior Notes due 2030 (the "Convertible Notes"), which includes the upsized offering of $100 million and the exercise in full of the $15 million option granted to the initial purchasers of the Convertible Notes. The initial conversion rate for the Convertible Notes is 303.9976 common shares per $1,000 principal amount of notes, which represents an initial conversion price of $3.2895 per common share.
enCore Energy Corp. Prices Upsized $100 Million Convertible Senior Notes Offering
prnewswire.com
2025-08-20 06:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 20, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today the pricing of $100 million aggregate principal amount of 5.50% Convertible Senior Notes due 2030 (the "Convertible Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering was upsized from the previously announced offering size of $75 million aggregate principal amount of Convertible Notes.
enCore Energy Corp. Announces Proposed Offering of $75 Million of Convertible Senior Notes Due 2030
prnewswire.com
2025-08-19 16:10:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 19, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today that it intends to offer, subject to market and other conditions, $75 million in aggregate principal amount of convertible senior notes due 2030 (the "Convertible Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). In connection with the offering of the Convertible Notes, enCore expects to grant the initial purchasers of the Convertible Notes a 13-day right to purchase up to an additional $11.25 million aggregate principal amount of Convertible Notes.
enCore Energy Announces Expansion of the Alta Mesa Uranium Project
prnewswire.com
2025-08-18 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 18, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy CompanyTM, today announced the acquisition of a 5,900 acre parcel of private land ("Tacubaya") located immediately adjacent to, and east of, enCore's Alta Mesa historic and producing wellfields and Central Processing Plant ("Alta Mesa Uranium Project"). Tacubaya is expected to provide additional feed and longevity for the Alta Mesa In-Situ Recovery ("ISR") Uranium Central Processing Plant ("CPP").
enCore Energy Reports Q2 2025 Financial Results, Highlighted by Increased Uranium Extraction Rates and Reduced Costs
prnewswire.com
2025-08-11 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , Aug. 11, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, today announced its financial and operational results for the six months ended June 30, 2025. Highlights for three months ended June 30, 2025 include: Three months ended June 30, 2025 net loss per share $(0.03) versus $(0.12) in same period 2024; Sale (delivery) into contract of 60,000 pounds of uranium ("U3O8") at a sales price of $61.07 and a weighted average cost of $42.23; Three months ended June 30 U3O8 extraction of 203,798 pounds, an increase of 89,983 pounds or an increase of 79% from the first quarter of 2025; Closing balance of 244,204 pounds of U3O8 in inventory at a cost of $39.63 per pound; Closing cash and equivalent balance of $26.9 million with working capital of $30.2 million.
Elanco Secures Approval of Zenrelia™ (ilunocitinib) in the European Union (EU), Launching Innovative Canine Dermatology Treatment for Itchy Dogs
prnewswire.com
2025-07-24 17:42:00The European Commission's Approval of Zenrelia reinforces safety and efficacy and further expands opportunities to treat itchy dogs around the world Launch to begin immediately with product in market before the end of Q3 2025 GREENFIELD, Ind. , July 24, 2025 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) announced today that Zenrelia™ (ilunocitinib) has received approval by the European Commission.
Down 40%, This 1 Super Growth Stock Can Double By 2026
247wallst.com
2025-07-14 09:29:19Key Points in This Article: enCore Energy's (EU) operational ISR plants and project pipeline position it to meet rising U.S.
enCore Energy Announces High Uranium Extraction Rates in South Texas; Commends Texas for Energizing its Nuclear Energy Strategy with Passage of Three Key Bills
prnewswire.com
2025-06-26 07:00:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , June 26, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announced today record uranium extraction rates from the Alta Mesa In-Situ Recovery ("ISR") Uranium Central Processing Plant ("CPP") since commencing operations in June 2024. Recent management changes and operational efficiencies have worked to expand uranium extraction and decrease costs.
enCore Energy Announces Filing of Early Warning Report
prnewswire.com
2025-06-20 19:57:00NASDAQ:EU TSXV:EU www.encoreuranium.com DALLAS , June 20, 2025 /PRNewswire/ - enCore Energy Corp. (NASDAQ: EU) (TSXV: EU) (the "Company" or "enCore"), America's Clean Energy Company™, announces that it has disposed of 170,000,000 common shares in the capital of Anfield Energy Inc. (" Anfield ") (TSX.V: AEC; OTCQB: ANLDF; FRANKFURT: 0AD) in a private agreement at a price of $0.115 per share for aggregate proceeds of $19,550,000 (Canadian dollars). Immediately following the disposition, enCore holds or controls no common shares of Anfield.
Guide to Aerospace & Defense ETFs
zacks.com
2025-06-05 08:31:03Defense spending hit a record $2.72T in 2024, boosting aerospace sector earnings as global tensions drive military budgets higher. ETFs like ITA, PPA and XAR are likely to gain.